antibodies Archives - tgiHealthCareerp

Harnessing antibodies as pathogen hunters

04/15/2021 antibodies, as, Harnessing, hunters, pathogen

On a microscopic level, humans face an existential threat every day. All sorts of tiny pathogens, like bacteria and viruses,

Health News

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

04/06/2021 ACE2, Angiotensin, antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, Glycine, Glycoprotein, Heparin, Immune Response, immunization, Nanoparticle, Nanoparticles, protein, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Health News

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

03/17/2021 Analyte, antibodies, Biosensor, Cell, Cell Imaging, coronavirus, Coronavirus Disease COVID-19, Diagnostics, Fluorescence, FRET, Imaging, protein, Quantum Dots, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, virus

In a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can

Health News

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

03/15/2021 antibodies, Cell, Chemokines, coronavirus, Cytokines, fever, Immune Response, inflammation, Intracellular, Lipids, Macrophage, Nanoparticle, Nanoparticles, Necroptosis, Nucleoside, Pain, peptides, Preclinical, protein, research, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine

Lipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and

Health News

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

03/15/2021 antibodies, antibody, assay, Cell, coronavirus, Coronavirus Disease COVID-19, Disability, efficacy, Enzyme, Glycoprotein, immune system, Immunodeficiency, in vitro, in vivo, Mortality, Mutation, pandemic, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine, virus

A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from

Health News

Scientists find evidence of monoclonal antibodies’ efficacy in fighting malarial infection

03/06/2021 antibodies, efficacy, evidence, Fighting, find, in, infection:, malarial, monoclonal, of, Scientists

Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can

Health Problems

New evidence COVID-19 antibodies, vaccines less effective against variants

03/04/2021 against, antibodies, covid 19, effective, evidence, Less, New, Vaccines, variants

New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus

Health News

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

02/18/2021 ACE2, AIDS, Angiotensin, Angiotensin-Converting Enzyme 2, antibodies, Cell, coronavirus, Coronavirus Disease COVID-19, Enzyme, Glycan, Glycans, Glycosylation, protein, Receptor, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, virus

Using simulations, a team of researchers in the U.S. found that the glycan at position N343 of the severe acute

Health News

SARS-CoV-2 D614G mutation associated with lower antibody binding

02/18/2021 antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, genome, Glycoprotein, immune system, Mutation, pandemic, protein, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, virus

The onset of the coronavirus disease 2019 (COVID-19) pandemic has brought about an international effort to uncover the biology of

Medications

Perjeta

01/31/2021 antibodies, blood, Breast Cancer, Breathing, cancer, chemotherapy, children, Cough, Diarrhoea, Docetaxel, Doctor, fever, Growth Factor, Headache, Heart, Herceptin, hives, hospital, inflammation, laboratory, Medicine, muscle, Nausea, Pain, Pharmacist, Pharmacy, Physical Activity, protein, Rash, Receptor, skin, surgery, throat, tongue, walking

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PERJETA 180903 Contains the active ingredient pertuzumab

← Previous